Sökning: "Her2 and dendritic cells"
Hittade 5 avhandlingar innehållade orden Her2 and dendritic cells.
1. The HER2/neu oncoprotein and dendritic cells in immunity against tumors
Sammanfattning : It is now well established that small peptide epitopes bound to the major histocompatibility complex (MHC), derived from processed proteins synthesized by the tumor cells, can be recognized as antigens by cytotoxic T lymphocytes (CTLs). A number of tumor antigens recognized by CTLs on human melanomas have been defined, but less is known about antigens from other tumor types. LÄS MER
2. Platforms and strategies harnessing signaling pathways of multifactorial diseases by multispecific antibodies
Sammanfattning : Abstract [ENG]Proteins govern a multitude of biological functions vital to sustain life. The ability to withstand diseases development and harboring a defense against foreign pathogens is attributed to the wonders of the immune system and the proteins and cells its comprised of. LÄS MER
3. Studies on polyomavirus virus-like particles : as vaccines and vectors for immune and gene therapy
Sammanfattning : Virus-like particles (VLPs) are similar to natural virus particles except that they lack viral genes. They have a similar cellular uptake to the natural virus from which they are derived but are non-infectious and can therefore not reproduce themselves. LÄS MER
4. Vaccination against Her2/neu : expressing cancer using chimeric virus-like particles
Sammanfattning : Thanks to the development of vaccines, children are these days protected against infectious diseases like polio, diphtheria and tetanus simply by receiving a few injections. Imagine a scenario where these injections would also result in protection against cancer. LÄS MER
5. Cancer therapy using viral and bacterial proteins as vectors for vaccines or as carriers of cytostatics
Sammanfattning : New cancer therapies are urgently needed, since available treatment options today have negative side effects, and cure only about half of the patients with invasive cancer. One, relatively new, option is to vaccinate against cancer, by introducing an antigen that is present on the tumor cells into the patient to stimulate specific immunity against the tumor. LÄS MER